AAPL 167.3 +3.34 (+2.04%)MSFT 104.11 +1.23 (+1.20%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 150.2 +6.7 (+4.67%)WBA 76.32 +0.25 (+0.34%)GOOG 1045.03 +27.51 (+2.70%)PIH 4.26 -0.74 (-14.80%)
AAPL 167.3 +3.34 (+2.04%)MSFT 104.11 +1.23 (+1.20%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 150.2 +6.7 (+4.67%)WBA 76.32 +0.25 (+0.34%)GOOG 1045.03 +27.51 (+2.70%)PIH 4.26 -0.74 (-14.80%)

Company Profile ADAP Quote Adaptimmune

Adaptimmune Therapeutics plc Quote

Adaptimmune The (ADAP)

4.25 -0.16 Healthcare

CEO

James J. Noble

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.